Article Details
Retrieved on: 2021-05-12 14:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
While the Serds have long held promise, Sanofi's competitors Roche and Astrazeneca have had several false starts, and the approach still lacks ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here